Loading…
CIK 0001907884 • 6 13F filings • May 15, 2025 – Aug 14, 2026
Import this data to Google Sheets with:
=jivedata("kynam-capital-management-lp","13f")Uses this filer's slug. Install the Jive Data add-on first; the second argument is "13f".
Past 5 quarters
| % of Portfolio | |||||
|---|---|---|---|---|---|
| ALECTOR INC | COM | $3.1M | 0.2% | 2,000,000 SH | New |
| AMARIN CORP PLC | SPONSORED ADR | $5.4M | 0.3%Prev: 0.7% | 389,273 SH | Decreased-186,838 SH |
| APELLIS PHARMACEUTICALS INC | COM | $22.8M | 1.5%Prev: 1.4% | 908,607 SH | Increased+100,000 SH |
| BEAM THERAPEUTICS INC | COM | $93.6M | 6.0%Prev: 4.5% | 3,377,214 SH | Increased+859,567 SH |
| BIOCRYST PHARMACEUTICALS INC | COM | $73.1M | 4.7%Prev: 5.3% | 9,366,526 SH | Increased-23,744 SH |
| BIOHAVEN LTD | COM | $7.9M | 0.5% | 702,884 SH | New |
| BURNING ROCK BIOTECH LTD | SPONSORED ADS | $20.0M | 1.3%Prev: 0.6% | 994,883 SH | Increased |
| CARIBOU BIOSCIENCES INC | COM | $4.0M | 0.3%Prev: 0.5% | 2,503,302 SH | Decreased-564,472 SH |
| CELLDEX THERAPEUTICS INC NEW | COM NEW | $161.4M | 10.3%Prev: 11.8% | 5,943,180 SH | Increased-157,549 SH |
| CG ONCOLOGY INC | COM | $39.3M | 2.5%Prev: 6.0% | 945,830 SH | Decreased-1,059,375 SH |
| CLIMB BIO INC | COM | $4.1M | 0.3%Prev: 0.2% | 1,028,341 SH | Increased |
| COGENT BIOSCIENCES INC | COM | $219.0M | 14.0%Prev: 8.4% | 6,165,223 SH | Increased-1,720,949 SH |
| CULLINAN THERAPEUTICS INC | COM | $32.2M | 2.1%Prev: 1.0% | 3,114,132 SH | Increased+811,960 SH |
| CYTOMX THERAPEUTICS INC | COM | $38.2M | 2.4%Prev: 0.9% | 8,966,077 SH | Increased+5,319,574 SH |
| DESIGN THERAPEUTICS INC | COM | $7.4M | 0.5%Prev: 0.6% | 784,606 SH | Decreased-244,973 SH |
| DYNAVAX TECHNOLOGIES CORP | COM NEW | $21.2M | 1.4%Prev: 1.6% | 1,375,632 SH | Decreased-769,687 SH |
| ENGENE HOLDINGS INC | COM | $13.5M | 0.9%Prev: 2.5% | 1,492,898 SH | Decreased-3,501,192 SH |
| EVOMMUNE INC | COM SHS | $3.2M | 0.2% | 185,482 SH | New |
| GERON CORP | COM | $4.6M | 0.3%Prev: 0.4% | 3,456,318 SH | Decreased |
| IMMUNOCORE HLDGS PLC | ADS | $29.7M | 1.9%Prev: 2.7% | 856,462 SH | Decreased-152,805 SH |
| KALVISTA PHARMACEUTICALS INC | COM | $29.2M | 1.9%Prev: 0.5% | 1,810,954 SH | Increased+1,204,783 SH |
| MBX BIOSCIENCES INC | COM | $29.5M | 1.9%Prev: 2.6% | 934,799 SH | Decreased-1,065,201 SH |
| NURIX THERAPEUTICS INC | COM | $37.4M | 2.4%Prev: 1.5% | 1,970,357 SH | Increased-198,248 SH |
| OMEROS CORP | COM | $3.4M | 0.2% | 200,000 SH | New |
| PHARVARIS N V | COM | $17.8M | 1.1%Prev: 1.3% | 640,395 SH | Increased-34,605 SH |
| PRELUDE THERAPEUTICS INC | COM | $2.3M | 0.1% | 788,867 SH | New |
| PROQR THRAPEUTICS N V | SHS EURO | $3.2M | 0.2%Prev: 0.3% | 1,566,317 SH | Decreased-83,145 SH |
| RELAY THERAPEUTICS INC | COM | $12.0M | 0.8%Prev: 1.1% | 1,424,259 SH | Decreased-1,462,755 SH |
| SUTRO BIOPHARMA INC | COM SHS | $5.5M | 0.4% | 479,590 SH | New |
| SYNDAX PHARMACEUTICALS INC | COM | $169.2M | 10.8%Prev: 9.8% | 8,050,959 SH | Increased-469,041 SH |
| TRAVERE THERAPEUTICS INC | COM | $19.8M | 1.3%Prev: 1.7% | 517,884 SH | Decreased-431,843 SH |
| TYRA BIOSCIENCES INC | COM | $41.1M | 2.6%Prev: 2.4% | 1,564,492 SH | Increased-765,506 SH |
| VAXCYTE INC | COM | $134.8M | 8.6%Prev: 8.2% | 2,922,335 SH | Increased-149,253 SH |
| VERA THERAPEUTICS INC | CL A | $173.8M | 11.1%Prev: 8.7% | 3,433,051 SH | Increased-594,749 SH |
| VIRIDIAN THERAPEUTICS INC | COM | $45.8M | 2.9%Prev: 7.1% | 1,470,541 SH | Decreased-2,957,386 SH |
| WAVE LIFE SCIENCES LTD | SHS | $36.9M | 2.4%Prev: 2.5% | 2,169,105 SH | Increased-2,390,948 SH |
| 13F-HR |
| 0001907884-26-000012 |
| $1.81B |
| View |
| Aug 14, 2025 | Q2 2025 | 13F-HR | 0001085146-25-005132 | $928.8M | View |
| May 15, 2026 | Q1 2026 | 13F-HR | 0001907884-26-000007 | $1.62B | View |
| May 15, 2025 | Q1 2025 | 13F-HR | 0001085146-25-003252 | $1.19B | View |